Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fireman B.V. (NQ: IFRX )

1.410 -0.110 (-7.24%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,167,685
Open 1.440
Bid (Size) 1.410 (18)
Ask (Size) 1.490 (3)
Prev. Close 1.520
Today's Range 1.360 - 1.550
52wk Range 0.7762 - 5.686
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering. 
Via Benzinga
InflaRx Provides Development Update For Vilobelimab In Skin Disorder, COVID-19
 
Via Benzinga

Performance

YTD
-68.53%
-68.53%
1 Month
-11.32%
-11.32%
3 Month
-38.96%
-38.96%
6 Month
-68.31%
-68.31%
1 Year
-53.77%
-53.77%

More News

Read More
LiveOne And 24 Stocks Moving Premarket
Via Benzinga
Read Why Did Raymond James Slash Price Target On Inflarx
Via Benzinga
Analyst Ratings for InflaRx
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Via Benzinga
Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
InflaRx Shares Plunge After Disappointing Results On Vilobelimab In Critically Ill COVID-19 Patients
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Recap: InflaRx Q4 Earnings
Via Benzinga
FDA Issues Corrected Advice To InflaRx's Vilobelimab Study In Skin Disease
Via Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
Via Benzinga
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Epizyme + 20 Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Via Benzinga
Recap: InflaRx Q1 Earnings
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
10 Biggest Price Target Changes For Friday
Via Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
Via Benzinga
See Why Did InflaRx Pause Late-Stage Vilobelimab Trial In Chronic Skin Condition
Via Benzinga
InflaRx's Vilobelimab Shows Encouraging Action Against Rare Autoimmune Disorder
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.